Long noncoding RNA NRAV in the 12q24.31 risk locus drives gastric cancer development through glucose metabolism reprogramming.

Long noncoding RNAs (lncRNAs) serve as vital candidates to mediate cancer risk. Here, we aimed to identify the risk single nucleotide polymorphisms (SNPs)-induced lncRNAs and to investigate their roles in gastric cancer (GC) development. Through integrating the differential expression analysis of lncRNAs in GC tissues and expression quantitative trait loci (eQTL) analysis in normal stomach tissues and GC tissues, as well as genetic association analysis based on GC genome-wide association studies (GWASs) and an independent validation study, we identified four lncRNA-related SNPs consistently associated with GC risk, including SNHG7 (OR = 1.16, 95%CI: 1.09 - 1.23), NRAV (OR = 1.11, 95%CI: 1.05 - 1.17), LINC01082 (OR = 1.16, 95%CI: 1.08 - 1.22) and FENDRR (OR = 1.16, 95%CI: 1.07 - 1.25). We further found that a functional SNP rs6489786 at 12q24.31 increases binding of MEOX1 or MEOX2 at a distal enhancer and results in upregulation of NRAV. The functional assays revealed that NRAV accelerates GC cell proliferation while inhibits GC cell apoptosis. Mechanistically, NRAV decreases the expression of key subunit genes through the electron transport chain, thereby driving the glucose metabolism reprogramming from aerobic respiration to glycolysis. These findings suggest that regulating lncRNA expression is a crucial mechanism for risk-associated variants in promoting GC development.